Skip to main content
OpenTrials
Completed

NCT Number: NCT06103695

Vtama in Psoriasis Patients Being Treated With Biologics.

Open label study to assess 12 weeks of add-on VTAMA® (tapinarof) Cream, 1% QD in patients with ≥3% BSA who have received biologic therapy for at least 24 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psoriasis Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Schweiger Derm Group

East Windsor, New Jersey, 08520, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female adult ≥ 18 years of age;
  • Diagnosis of chronic plaque-type
  • Patient with ≥3% BSA
  • Patient has been treated with biologic for a minimum of 24 weeks
  • Able and willing to give written informed consent prior to performance of any study-related procedures.

Exclusion criteria

  • ≤3% BSA
  • Patient not receiving biologic agent, or receiving biologic agent <24weeks

Treatment and study plan

Tapinarof

Drug

Add on Vtama (tapinarof) to biololgic therapy

Primary outcomes

  1. Body surface area ≤1%

    Time frame: 12 weeks

    Patients who achieve body surface area of ≤1%

Sponsors and collaborators

Lead sponsor

Psoriasis Treatment Center of Central New Jersey

Other

Registry information

Official study title

Open Label, Observational Study, Evaluating VTAMA® (Tapinarof) Cream, 1% QD in Psoriasis Patients Being Treated With Biologic Agents.

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Oct 27, 2023
Registry last updated
Oct 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.